Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 643

1.

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.

van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL.

United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.

2.

Recovery and prognostic value of myocardial strain in ST-segment elevation myocardial infarction patients with a concurrent chronic total occlusion.

Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, Piek JJ, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Henriques JPS, Hirsch A; EXPLORE investigators.

Eur Radiol. 2019 Jul 26. doi: 10.1007/s00330-019-06338-x. [Epub ahead of print]

PMID:
31350585
3.

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.

Salah K, Stienen S, Moons AHM, Bakx ALM, van Pol PE, Kortz RAM, Ferreira JP, Marques I, Schroeder-Tanka JM, Keijer JT, Bayes-Genis A, Pinto YM, Tijssen JG, Kok WE.

J Am Heart Assoc. 2019 Jul 16;8(14):e010309. doi: 10.1161/JAHA.118.010309. Epub 2019 Jul 12.

4.

Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.

Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, Escaned J, Gori T, Kočka V, Tarantini G, West NEJ, Morice MC, Tijssen JGP, van Geuns RJ, Smits PC; COMPARE ABSORB trial investigators.

Cardiovasc Revasc Med. 2019 Jul;20(7):577-582. doi: 10.1016/j.carrev.2019.04.013. Epub 2019 Apr 16.

5.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.

Kerkmeijer LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout KE, Kraak RP, Weevers A, Piek JJ, de Winter RJ, Tijssen JGP, Henriques JPS, Wykrzykowska JJ, Ijsselmuiden A, Kauer F, Beijk MA, Vis M, Koch K.

EuroIntervention. 2019 May 23. pii: EIJ-D-19-00325. doi: 10.4244/EIJ-D-19-00325. [Epub ahead of print] No abstract available.

6.

Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.

Vlastra W, Chandrasekhar J, Vendrik J, Gutierrez-Ibanes E, Tchétché D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, Pan M, Dumonteil N, Mangione JA, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Sanchez Gila J, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R.

JACC Cardiovasc Interv. 2019 May 27;12(10):911-920. doi: 10.1016/j.jcin.2019.02.031.

PMID:
31122347
7.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
8.

Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score.

Kraak RP, Tijssen RYG, van Dongen IM, Elias J, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Tijssen JGP, Piek JJ, de Winter RJ, Henriques JPS, Wykrzykowska JJ; Collaborators.

EuroIntervention. 2019 May 7. pii: EIJ-D-18-00884. doi: 10.4244/EIJ-D-18-00884. [Epub ahead of print]

9.

Impact of atrial septal defect closure on diffusing capacity for nitric oxide and carbon monoxide.

Nassif M, van Steenwijk RP, van der Lee I, Sterk PJ, de Jongh FHC, Hogenhout JM, Tijssen JGP, Mulder BJM, de Winter RJ.

ERJ Open Res. 2019 Apr 8;5(2). pii: 00260-2018. doi: 10.1183/23120541.00260-2018. eCollection 2019 Apr.

10.

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.

Tijssen RYG, van der Schaaf RJ, Kraak RP, Vink MA, Hofma SH, Arkenbout EK, Weevers APJD, Kerkmeijer LSM, Onuma Y, Serruys PW, Beijk MAM, Koch KT, Baan J Jr, Vis MM, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ.

Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28193. [Epub ahead of print]

PMID:
30968559
11.

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.

Salah K, Stienen S, Pinto YM, Eurlings LW, Metra M, Bayes-Genis A, Verdiani V, Tijssen JGP, Kok WE.

Heart. 2019 Aug;105(15):1182-1189. doi: 10.1136/heartjnl-2018-314173. Epub 2019 Apr 8.

12.

The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial.

Tijssen RYG, Kerkmeijer LSM, Katagiri Y, Kraak RP, Takahashi K, Kogame N, Chichareon P, Modolo R, Asano T, Nassif M, Kalkman DN, Sotomi Y, Collet C, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Beijk MAM, Piek JJ, Tijssen JGP, Henriques JP, de Winter RJ, Onuma Y, Serruys PW, Wykrzykowska JJ.

Int J Cardiovasc Imaging. 2019 Jul;35(7):1189-1198. doi: 10.1007/s10554-019-01576-y. Epub 2019 Mar 25.

13.

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial.

Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang CC, Spitzer E, Walsh SJ, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen JGP, Rademaker-Havinga T, Garg S, Steg PG, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt FWA.

EuroIntervention. 2019 Mar 19. pii: EIJ-D-19-00202. doi: 10.4244/EIJ-D-19-00202. [Epub ahead of print]

14.

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.

Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Lenderink T, Widdershoven J, Bucx JJJ, Rienstra M, Kamp O, Van Opstal JM, Alings M, Oomen A, Kirchhof CJ, Van Dijk VF, Ramanna H, Liem A, Dekker LR, Essers BAB, Tijssen JGP, Van Gelder IC, Crijns HJGM; RACE 7 ACWAS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1499-1508. doi: 10.1056/NEJMoa1900353. Epub 2019 Mar 18.

PMID:
30883054
15.

Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke.

Vlastra W, Jimenez-Quevedo P, Tchétché D, Chandrasekhar J, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, De la Torre Hernandez JM, Dumonteil N, Sarmento-Leite R, Sartori S, Rosato S, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Hernandez-Antolin R, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007546. doi: 10.1161/CIRCINTERVENTIONS.118.007546.

PMID:
30871358
16.

18F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction.

Nakahara T, Narula J, Tijssen JGP, Agarwal S, Chowdhury MM, Coughlin PA, Dweck MR, Rudd JHF, Jinzaki M, Mulhall J, Strauss HW.

J Am Coll Cardiol. 2019 Apr 2;73(12):1386-1394. doi: 10.1016/j.jacc.2018.10.076. Epub 2019 Mar 4.

PMID:
30846336
17.

Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.

De With RR, Rienstra M, Smit MD, Weijs B, Zwartkruis VW, Hobbelt AH, Alings M, Tijssen JGP, Brügemann J, Geelhoed B, Hillege HL, Tukkie R, Hemels ME, Tieleman RG, Ranchor AV, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC.

Europace. 2019 Apr 1;21(4):563-571. doi: 10.1093/europace/euy311.

PMID:
30629160
18.

Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration.

Vlastra W, Chandrasekhar J, Muñoz-Garcia AJ, Tchétché D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, Trillo-Nouche R, Dumonteil N, Abizaid A, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Del Valle R, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R.

Eur Heart J. 2019 Feb 1;40(5):456-465. doi: 10.1093/eurheartj/ehy805.

PMID:
30590565
19.

Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.

Kalkman DN, Kerkmeijer LS, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2018 Dec 18. doi: 10.1002/ccd.28047. [Epub ahead of print]

PMID:
30565371
20.

Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization.

Zivelonghi C, Suttorp MJ, Teeuwen K, van Kuijk JP, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, van den Brink FS, Benfari G, Tijssen JGP, Ribichini F, Henriques JPS, Agostoni P.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2343-2345. doi: 10.1016/j.jcin.2018.07.038. No abstract available.

PMID:
30466836
21.

Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.

Ouweneel DM, de Brabander J, Karami M, Sjauw KD, Engström AE, Vis MM, Wykrzykowska JJ, Beijk MA, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, Cherpanath TG, Driessen AH, Cocchieri R, de Mol BA, Tijssen JG, Henriques JP.

Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):338-349. doi: 10.1177/2048872618805486. Epub 2018 Nov 7.

22.

1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.

de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038.

PMID:
30286855
23.

Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.

Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2.

PMID:
30280464
24.

Guideline-defined futility or patient-reported outcomes to assess treatment success after TAVI: what to use? Results from a prospective cohort study with long-term follow-up.

van Mourik MS, Vendrik J, Abdelghani M, van Kesteren F, Henriques JPS, Driessen AHG, Wykrzykowska JJ, de Winter RJ, Piek JJ, Tijssen JG, Koch KT, Baan J, Vis MM.

Open Heart. 2018 Sep 23;5(2):e000879. doi: 10.1136/openhrt-2018-000879. eCollection 2018.

25.

Atrial septal defect in adults is associated with airway hyperresponsiveness.

Nassif M, van Steenwijk RP, Hogenhout JM, Lu H, de Bruin-Bon RHACM, Hirsch A, Sterk PJ, Bouma BJ, Straver B, Tijssen JGP, Mulder BJM, de Winter RJ.

Congenit Heart Dis. 2018 Nov;13(6):959-966. doi: 10.1111/chd.12665. Epub 2018 Sep 21.

PMID:
30242971
26.

Corrigendum to 'Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device' [American Journal of Cardiology (2018) 856-861].

Vendrik J, van Kesteren F, van Mourik MS, Piek JJ, Tijssen JG, Henriques JPS, Wykrzykowska JJ, de Winter RJ, Driessen AHG, Kaya A, Vis MM, Koch KT, Baan J Jr.

Am J Cardiol. 2018 Dec 15;122(12):2172-2173. doi: 10.1016/j.amjcard.2018.07.009. Epub 2018 Aug 27. No abstract available.

PMID:
30166047
27.

In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures.

König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Andrié R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A.

Eur Heart J. 2018 Nov 21;39(44):3947-3957. doi: 10.1093/eurheartj/ehy528.

PMID:
30165430
28.

Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis.

Collet C, Onuma Y, Sonck J, Asano T, Vandeloo B, Kornowski R, Tu S, Westra J, Holm NR, Xu B, de Winter RJ, Tijssen JG, Miyazaki Y, Katagiri Y, Tenekecioglu E, Modolo R, Chichareon P, Cosyns B, Schoors D, Roosens B, Lochy S, Argacha JF, van Rosendael A, Bax J, Reiber JHC, Escaned J, De Bruyne B, Wijns W, Serruys PW.

Eur Heart J. 2018 Sep 14;39(35):3314-3321. doi: 10.1093/eurheartj/ehy445.

PMID:
30137305
29.

Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial.

van Dongen IM, Elias J, van Houwelingen KG, Agostoni P, Claessen BEPM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Piek JJ, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, van der Schaaf RJ, Tijssen JGP, Henriques JPS.

Open Heart. 2018 Jul 16;5(2):e000810. doi: 10.1136/openhrt-2018-000810. eCollection 2018.

30.

Short versus conventional hydration for prevention of kidney injury during pre-TAVI computed tomography angiography.

van Mourik MS, van Kesteren F, Planken RN, Stoker J, Wiegerinck EMA, Piek JJ, Tijssen JG, Koopman MG, Henriques JPS, Baan J Jr, Vis MM.

Neth Heart J. 2018 Sep;26(9):425-432. doi: 10.1007/s12471-018-1133-1.

31.

Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases.

van der Wel MJ, Duits LC, Klaver E, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Tijssen JG, Bergman J, Meijer SL.

United European Gastroenterol J. 2018 Jul;6(6):830-837. doi: 10.1177/2050640618764710. Epub 2018 Mar 7.

32.

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Valgimigli M, Garcia-Garcia HM, Vrijens B, Vranckx P, McFadden EP, Costa F, Pieper K, Vock DM, Zhang M, Van Es GA, Tricoci P, Baber U, Steg G, Montalescot G, Angiolillo DJ, Serruys PW, Farb A, Windecker S, Kastrati A, Colombo A, Feres F, Jüni P, Stone GW, Bhatt DL, Mehran R, Tijssen JGP.

Eur Heart J. 2019 Jul 1;40(25):2070-2085. doi: 10.1093/eurheartj/ehy377.

PMID:
29992264
33.

Trends in patient characteristics and clinical outcome over 8 years of transcatheter aortic valve implantation.

van Kesteren F, van Mourik MS, Wiegerinck EMA, Vendrik J, Piek JJ, Tijssen JG, Koch KT, Henriques JPS, Wykrzykowska JJ, de Winter RJ, Driessen AHG, Kaya A, Planken RN, Vis MM, Baan J.

Neth Heart J. 2018 Sep;26(9):445-453. doi: 10.1007/s12471-018-1129-x.

34.

Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review.

Abdelghani M, Nassif M, Blom NA, Van Mourik MS, Straver B, Koolbergen DR, Kluin J, Tijssen JG, Mulder BJM, Bouma BJ, de Winter RJ.

J Am Heart Assoc. 2018 Jun 22;7(13). pii: e008163. doi: 10.1161/JAHA.117.008163. Review.

35.

Predictors of residual tricuspid regurgitation after percutaneous closure of atrial septal defect.

Nassif M, van der Kley F, Abdelghani M, Kalkman DN, de Bruin-Bon RHACM, Bouma BJ, Schalij MJ, Koolbergen DR, Tijssen JGP, Mulder BJM, de Winter RJ.

Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):225-232. doi: 10.1093/ehjci/jey080.

PMID:
29905827
36.

Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury.

van der Weg K, Kuijt WJ, Bekkers SCAM, Tijssen JGP, Green CL, Smulders MW, Lemmert ME, Krucoff MW, Gorgels APM.

Int J Cardiol. 2018 Nov 15;271:240-246. doi: 10.1016/j.ijcard.2018.05.083. Epub 2018 May 30.

PMID:
29885829
37.

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI.

Tijssen RYG, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Elias J, van Dongen IM, Koch KT, Baan J Jr, Vis M, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS, Wykrzykowska JJ.

EuroIntervention. 2018 Jul 20;14(4):e426-e433. doi: 10.4244/EIJ-D-18-00335.

38.

Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial.

Zivelonghi C, Teeuwen K, Agostoni P, van der Schaaf RJ, Ribichini F, Adriaenssens T, Kelder JC, Tijssen JGP, Henriques JPS, Suttorp MJ.

J Interv Cardiol. 2018 Oct;31(5):580-587. doi: 10.1111/joic.12516. Epub 2018 May 1.

PMID:
29717512
39.

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial.

Tijssen RYG, Kraak RP, Elias J, van Dongen IM, Kalkman DN, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek JJ, Henriques JPS, de Winter RJ, Tijssen JGP, Onuma Y, Serruys PW, Wykrzykowska JJ.

EuroIntervention. 2018 Jul 20;14(4):e434-e442. doi: 10.4244/EIJ-D-17-01152.

40.

Five-year clinical follow-up of the STENTYS self-apposing stent in complex coronary anatomy: a single-centre experience with report of specific angiographic indications.

Lu H, Bekker RJ, Grundeken MJ, Woudstra P, Wykrzykowska JJ, Tijssen JGP, de Winter RJ, Koch KT.

Neth Heart J. 2018 May;26(5):263-271. doi: 10.1007/s12471-018-1111-7.

41.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
42.

Impact of Coronary Remodeling on Fractional Flow Reserve.

Collet C, Katagiri Y, Miyazaki Y, Asano T, Sonck J, van Geuns RJ, Andreini D, Bittencourt MS, Kitslaar P, Tenekeciouglu E, Tijssen JGP, Piek JJ, de Winter RJ, Cosyns B, Rogers C, Zarins CK, Taylor C, Onuma Y, Serruys PW.

Circulation. 2018 Feb 13;137(7):747-749. doi: 10.1161/CIRCULATIONAHA.117.031478. No abstract available. Erratum in: Circulation. 2018 Oct 23;138(17):e617.

PMID:
29440200
43.

Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis.

Ren B, Spitzer E, Geleijnse ML, Zijlstra F, de Jaegere PPT, Van Mieghem NM, Tijssen JG.

Int J Cardiol. 2018 Apr 15;257:40-45. doi: 10.1016/j.ijcard.2018.01.117. Epub 2018 Jan 31. Review.

PMID:
29422266
44.

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial.

Vranckx P, Lewalter T, Valgimigli M, Tijssen JG, Reimitz PE, Eckardt L, Lanz HJ, Zierhut W, Smolnik R, Goette A.

Am Heart J. 2018 Feb;196:105-112. doi: 10.1016/j.ahj.2017.10.009. Epub 2017 Oct 23.

45.

Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device.

Vendrik J, van Kesteren F, van Mourik MS, Piek JJ, Tijssen JG, Henriques JPS, Wykrzykowska JJ, de Winter RJ, Driessen AHG, Kaya A, Vis MM, Koch KT, Baan J Jr.

Am J Cardiol. 2018 Apr 1;121(7):856-861. doi: 10.1016/j.amjcard.2017.12.024. Epub 2018 Jan 11. Erratum in: Am J Cardiol. 2018 Dec 15;122(12):2172-2173.

PMID:
29415808
46.

A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.

Baan J Jr, Claessen BE, Dijk KB, Vendrik J, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, de Winter RJ, Koch KT, Sjauw KD, Beijk MA, Vis MM, Wykrzykowska JJ, Piek JJ, Tijssen JGP, Henriques JPS.

JACC Cardiovasc Interv. 2018 Feb 12;11(3):275-283. doi: 10.1016/j.jcin.2017.10.024. Epub 2017 Nov 7.

47.

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.

Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brügemann J, Geelhoed B, Tieleman RG, Hillege HL, Tukkie R, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC; RACE 3 Investigators.

Eur Heart J. 2018 Aug 21;39(32):2987-2996. doi: 10.1093/eurheartj/ehx739.

PMID:
29401239
48.

Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography.

Kraak RP, Kajita AH, Garcia-Garcia HM, Henriques JPS, Piek JJ, Arkenbout EK, van der Schaaf RJ, Tijssen JGP, de Winter RJ, Wykrzykowska JJ.

Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E106-E114. doi: 10.1002/ccd.27475. Epub 2018 Jan 14.

PMID:
29332307
49.

Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining.

van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL.

Histopathology. 2018 May;72(6):1015-1023. doi: 10.1111/his.13462. Epub 2018 Feb 28.

PMID:
29314176
50.

1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery Disease.

Kalkman DN, Tijssen RYG, Kraak RP, Woudstra P, Beijk MA, Tijssen JGP, Piek JJ, Henriques JPS, de Winter RJ, Wykrzykowska JJ.

JACC Cardiovasc Interv. 2018 Jan 8;11(1):102-103. doi: 10.1016/j.jcin.2017.10.006. No abstract available.

Supplemental Content

Loading ...
Support Center